GLP-1 and PCOS: How Semaglutide and Tirzepatide Help With Insulin Resistance and Weight

You moved to Phuket eight months ago, or your stay stretched well past what you planned. The prescription you brought with you has run out. Your period has gone irregular again. The weight you managed to lose before leaving is creeping back. You know what worked at home. You just do not know how to get it here.

This is a common situation for people managing chronic conditions across borders. PCOS does not pause because you changed countries, and insulin resistance does not care that you are on a beautiful island. This article explains what the evidence says about GLP-1 medications and PCOS, what the honest differences are between semaglutide and tirzepatide, and what to expect if you want to start or continue treatment here.

Why Insulin Resistance Is the Central Problem in PCOS

PCOS is not simply a reproductive condition. For many women, the driver underneath the symptoms is insulin resistance. When your cells resist insulin, your body produces more of it to compensate. High insulin then signals the ovaries to produce more androgens, the male-type hormones like testosterone. That androgen excess is what causes irregular periods, acne, excess hair growth, and difficulty losing weight.

This is why treating insulin resistance often improves the hormonal picture, not just the weight. And it is why GLP-1 medications have attracted serious research attention in PCOS management.

How GLP-1 Medications Work Beyond Weight Loss in PCOS

GLP-1 receptor agonists slow stomach emptying, reduce appetite, lower blood glucose after meals, and improve how your cells respond to insulin. The weight loss that follows is real and often significant. But in PCOS, something else happens too.

As insulin levels fall, the liver produces more sex hormone-binding globulin, or SHBG. SHBG binds to free testosterone, which means less of it is available to cause symptoms. There is also evidence from clinical reviews that GLP-1 medications influence the hormonal signalling chain between your brain and your ovaries. This may be part of why some women see menstrual cycle improvement beyond what weight loss alone would explain.

These hormonal effects are documented in published reviews but remain an active area of research. They are not the primary reason these medications are prescribed, but they matter if you want to understand the full picture.

Semaglutide vs Tirzepatide for PCOS: What the Evidence Shows

Semaglutide acts on GLP-1 receptors only. Tirzepatide acts on both GLP-1 receptors and GIP receptors, another gut hormone pathway involved in insulin response. In the 2025 SURMOUNT-5 trial published in the New England Journal of Medicine, tirzepatide produced greater average weight loss than semaglutide in adults with obesity.

For PCOS specifically, semaglutide has more published trial data. Some randomised trials have found that adding a GLP-1 medication to metformin outperformed metformin alone on metabolic markers in women with PCOS. Evidence on pregnancy rates specifically for semaglutide is still preliminary, with key trials registered but not yet fully reported. Tirzepatide’s dual receptor action produces stronger insulin sensitivity gains in general trials, which is relevant in PCOS where insulin resistance is central.

There is no direct head-to-head PCOS trial comparing the two yet. Both are used off-label for PCOS. The better option depends on your metabolic profile, your weight loss goals, and what a physician assesses after reviewing your history and blood results. At Takecare Clinic Phuket, that assessment includes the blood tests that matter before any prescription decision is made.

Can GLP-1 Restore Your Period and Help With Fertility?

Some women with PCOS see their periods become more regular after starting a GLP-1 medication. Published meta-analyses have documented improved menstrual cyclicity in women using GLP-1 receptor agonists, with the effect appearing linked to both weight reduction and the hormonal changes described above.

On fertility, the picture is cautiously positive but not settled. Some GLP-1 trials in PCOS have reported improved ovulation rates, which may support conception, but published pregnancy rate data for semaglutide specifically remains preliminary. Anovulation, where the ovaries do not release an egg, is a core feature of PCOS, and restoring ovulation can improve the chances of conceiving.

There is an important caveat here. GLP-1 medications must be stopped before trying to conceive and are not used during pregnancy. The safety data in pregnancy is insufficient, and this is not a grey area. If fertility is your goal, the timing of treatment needs a proper clinical conversation. You can read more on GLP-1 and fertility with PCOS before your appointment.

Side Effects and Who Should Not Use These Medications

The most common side effects of both semaglutide and tirzepatide are gastrointestinal: nausea, vomiting, and loose stools, particularly in the first weeks. These typically ease as the body adjusts to dose increases. Starting at a low dose and titrating slowly is standard practice to reduce this.

Some women cannot use these medications at all. GLP-1 receptor agonists are not suitable for patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. They are not used in pregnancy. They require caution in patients with a history of pancreatitis or severe gastrointestinal disease. Anyone with type 1 diabetes needs specialist-level assessment before GLP-1 use is considered.

These are not minor points. They are the reason this medication needs a physician’s assessment, not a pharmacy counter decision.

Getting a GLP-1 Prescription for PCOS in Phuket

Managing a chronic condition when you are far from your regular doctor is genuinely difficult. Prescription continuity is a genuine challenge: you brought enough medication for two months, you stayed for four, and now you need a clinical review to continue.

Takecare Clinic Phuket sees patients from Bang Tao and Laguna in the north to Rawai and Nai Harn in the south for exactly this kind of ongoing care. An English-speaking doctor in Phuket can review your history, order relevant blood tests including fasting glucose, insulin, and hormone levels, and discuss whether semaglutide or tirzepatide is appropriate for your situation. No appointment is needed.

If you already have a prescription from home and need a review and continuation, our prescription refill service is designed for exactly that. If you are starting from scratch, we assess fully before prescribing. You sit with a doctor who can examine you, look at your results, and make a clinical call.

For broader hormone-related health concerns that often accompany PCOS, including recurrent infections or other metabolic issues, these can be handled in the same visit. Our blood test services in Phuket cover all the markers relevant to a GLP-1 assessment without sending you across the island for separate referrals.